Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer

Anticancer Research

Volumn 25, Issue 1 B, 2005, Pages 489-495

  Ishiwata, Toshiji ^a   Takahashi, Kazuhisa ^a   Shimanuki, Yuri ^a   Ohashi, Rina ^a   Cui, Ri ^a   Takahashi, Fumiyuki ^a   Shimizu, Kazue ^a   Miura, Kayo ^a   Fukuchi, Yoshinosuke ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Microvessel density (MVD); Non small cell lung cancer (NSCLC); Tenascin (Tn C) C; Vascular endothelial growth factor (VEGF)

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; OSTEOPONTIN; SIALYL LEWIS X ANTIGEN; TENASCIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL MIGRATION; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STROMA; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OLIGOSACCHARIDES; OSTEOPONTIN; PROGNOSIS; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; TENASCIN; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 16344368253     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kaneko S, Ishikawa K, Yoshimi I, Marugame T, Hamashima C, Kamo K, Mizuno S and Sobue T: Projection of lung cancer mortality in Japan. Cancer Sci 94: 919-923, 2003.
2. Marugome T and Mizuno S: Mortality trend of lung cancer in Japan: 1960-2000. Jpn J Clin Oncol 33: 148-149, 2003.
3. Folkman J, Watson K, Ingber D and Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61, 1989.
4. Weidner N, Folkman J and Pozza F: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992.
5. Johnson B: Adjuvant chemotherapy for non-small cell lung cancer: the end of the beginning. J Natl Cancer Inst 95: 1422-1424, 2003.
6. Evans T: Highlights from the Tenth World Conference on Lung Cancer. Oncologist 9: 232-238, 2004.
7. Jones F and Jones P: The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 218: 235-259, 2000.
8. Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, Katsuta K, Sakakura T, Majima Y and Yoshida K: Involvement of large Tenascin-C splice variants in breast cancer progression. Am J Pathol 162: 1857-1867, 2003.
9. Mighell A, Thompson J, Hume W, Markham A and Robinson P: Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant, and reative oral mucosae. Int J Cancer 72: 236-240, 1997.
10. Atula T, Hedstrom J, Finne P, Leivo I, Markkanen-Leppanen M and Haglund C: Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res 23: 3051-3056, 2003.
11. Mai J, Sameni M, Mikkelsen T and Sloane B: Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas. Biol Chem 383: 1407-1413, 2002.
12. Zagzag D, Friedlander D, Dosik J, Chikramane S, Chan W, Greco M, Allen J, Dorovini-Zis K and Grumet M: Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 56: 182-189, 1996.
13. Zagzag D and Capo V: Angiogenesis in the central nervous system: a role for vascular endothelial growth factor/vascular permeability factor and tenascin-C. Common molecular effectors in cerebral neoplastic and non-neoplastic "angiogenic diseases". Histol Histopathol 17: 301-321, 2002.
14. Kim C, Bak K, Kim Y, Kim J, Ko Y, Oh S, Kim K and Hong E: Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis. Surg Neurol 54: 235-240, 2000.
15. Riedl S, Bodenmuller H, Hinz U, Holle R, Moller P, Schlag P, Herfarth C and Faissner A: Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int J Cancer 20: 65-69, 1995.
16. Burchardt E, Hein R and Bosserhoff A: Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma. Clin Exp Dermatol 28: 515-520, 2003.
17. Pauli C, Stieber P, Schmitt U, Andratschke M, Hoffmann K and Wollenberg B: The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck. Anticancer Res 22: 3093-3097, 2002.
18. Kusagawa H, Onoda K, Namikawa S, Yada I, Okada A, Yoshida T and Sakakura T: Expression and degeneration of tenascin-C in human lung cancers. Br J Cancer 77: 98-102, 1998.
19. Cai M, Onoda K, Takao M, Kyoko I, Shimpo H, Yoshida T and Yada I: Degradation of tenascin-C and activity of matrix metalloproteinase-2 are associated with tumor recurrence in early stage non-small cell lung cancer. Clin Cancer Res 8: 1152-1156, 2002.
20. Soini Y, Paakko P, Nuorva K, Kamel D, Linnala A, Virtanen I and Lehto V: Tenascin immunoreactivity in lung tumors. Am J Clin Pathol 100: 145-150, 1993.
21. Dhar D, Ono T, Yamanoi A, Soda Y, Yamaguchi E, Rahman M, Kohno H and Nagasue N: Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Cancer 95: 2188-2195, 2002.
22. Zagzag D, Shiff B, Jallo G, Greco M, Blanco C, Cohen H, Hukin J, Allen J and Friedlander D: Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. Cancer Res 62: 2660-2668, 2002.
23. Hirama M, Takahashi F, Takahashi K, Akutagawa S, Shimizu K, Soma S, Shimanuki Y, Nishio K and Fukuchi Y: Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth. Cancer Lett 198: 107-117, 2003.
24. Tanaka K, Hiraiwa N, Hashimoto H, Yamazaki Y and Kusakabe M: Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor. Int J Cancer 108: 31-40, 2004.
25. Tokes A, Hortovanyi E, Kulka J, Jackel M, Kerenyi T and Kadar A: Tenascin expression and angiogenesis in breast cancers. Pathol Res Pract 195: 821-828, 1999.
26. Ylatupa S, Mertaniemi P, Haglund C and Partanen P: Enzyme immunoassay for quantification of tenascin in biologic samples. Clin Biochem 28: 263-268, 1995.
27. Yamauchi M, Mizuhara Y, Maezawa Y and Toda G: Serum tenascin levels in chronic liver disease. Liver 14: 148-153, 1994.
28. Juhasz A, Bardos H, Repassy G and Adany R: Characteristic distribution patterns of tenascin in laryngeal and hypopharyngeal cancers. Laryngoscope 110: 84-92, 2000.
29. Korshunov A, Golanov A, Ozerov S and Sycheva R: Prognostic value of tumor-associated antigens immunoreactivity and apoptosis in medulloblastomas. Brain Tumor Pathol 16: 37-44, 1999.
30. Pilch H, Schaffer U, Schlenger K, Lautz A, Tanner B, Hockel M and Knapstein P: Expression of tenascin in human cervical cancer-association of tenascin expression with clinicopathological parameters. Gynecol Oncol 73: 415-421, 1999.
31. Jahkola T, Toivonen T, Virtanen I, von Smitten K, Nordling S, von Boguslawski K, Haglund C, Nevanlinna H and Blomqvist C: Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer 78: 1507-1513, 1998.
32. Ishihara A, Yoshida T, Tamaki H and Sakakura T: Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res 1: 1035-1041, 1995.
33. Iskaros B, Hu X, Sparano J and Fineberg S: Tenascin pattern of expression and established prognostic factors in invasive breast carcinoma. J Surg Oncol 68: 107-112, 1998.
34. Iskaros B, Tanaka K, Hu X, Kadish A and Steinberg J: Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer. J Surg Oncol 64: 98-101, 1997.
35. Kressner U, Lindmark G, Tomasini-Johansson B, Bergstrom R, Gerdin B, Pahlman L and Glimelius B: Stromal tenascin distribution as a prognostic marker in colorectal cancer. Br J Cancer 76(4): 526-30: 526-530, 1997.
36. Jahkola T, Toivonen T, von Smitten K, Blomqvist C and Virtanen I: Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer 69: 445-447, 1996.
37. Shoji T, Kamiya T, Tsubura A, Hamada Y, Hatano T, Hioki K and Morii S: Tenascin staining positivity and the survival of patients with invasive breast carcinoma. J Surg Res 55: 295-297, 1993.